MedPath

A study to improve the pregnancy outcome using moblie technology

Not yet recruiting
Conditions
Other obstetric conditions, not elsewhere classified,
Registration Number
CTRI/2025/06/089593
Lead Sponsor
Lothunglo Ezung
Brief Summary

This randomized controlled trial evaluates the impact of the SwasthGarbh mobile application on antenatal care among pregnant women in Northeast India. Conducted at AIIMS Guwahati, the study includes 190 participants, randomly divided into intervention and control groups. Women in the intervention group received standard antenatal care along with access to the SwasthGarbh app, while the control group received only standard care. The app provides features like appointment reminders, educational content, symptom tracking, and guidance on investigations and supplement intake. The study aims to improve maternal hemoglobin levels, antenatal visit compliance, and reduce obstetric and medical complications. It also seeks to enhance maternal knowledge and satisfaction with care. Participants will be recruited  from the first trimester and followed out the through delivery. The study targets the underserved tribal population, aiming to bridge the digital health gap and promote evidence-based maternal care. Findings are expected to support the wider use of mHealth tools to strengthen maternal health services in low-resource settings.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
190
Inclusion Criteria

1IMPROVED ANTENATAL CARE COMPLIANCE -BETTER ADHERENCE TI ANTENATAL CHECKUPTESTS AND SUPPLEMENTS 2IMPROVED HAEMOGLOBIN LEVEL 3EARLIER DETECTION OF PREGNANCY COMPLICATIONS 4TO ASSESS COMPLIANCE TO TIMELY SUPPLEMENY=TS INTAKE AND LABORATORY INVESTIGATIONS.

Exclusion Criteria

Women with comorbidities like chronic diseases.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Improved antenatal care compliance - better adherence to antenatal checkup, tests and supplements.Participants will be recruited from the first six months of study period till the target sample size is reached and they will be followed up till delivery
2. Improved hemoglobin level.Participants will be recruited from the first six months of study period till the target sample size is reached and they will be followed up till delivery
3. Earlier detection of pregnancy complications.Participants will be recruited from the first six months of study period till the target sample size is reached and they will be followed up till delivery
4. To assess compliance to timely supplement intake and laboratory investigations.Participants will be recruited from the first six months of study period till the target sample size is reached and they will be followed up till delivery
Secondary Outcome Measures
NameTimeMethod
1. Improved maternal knowledge and awareness after app usage.2. Better pregnancy experience and improved patient satisfaction.

Trial Locations

Locations (1)

AIIMS Guwahati

🇮🇳

Kamrup, ASSAM, India

AIIMS Guwahati
🇮🇳Kamrup, ASSAM, India
Lothunglo Ezung
Principal investigator
7005773408
ezunglolo15@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.